Stock listing
REGN Stock Price, News, Filings & Events — Regeneron Pharmaceuticals, Inc.
Selected listing: REGN · BOATS · USD · US
This page tracks Regeneron Pharmaceuticals, Inc.'s REGN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REGN:BOATS. REGN:BOATS is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regeneron Pharmaceuticals, Inc. is a public company traded on the American stock market under the ticker REGN. The company has a market capitalization of approximately $68.8 billion. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.
- Ticker
- REGN:BOATS
- Asset type
- Stock
- Market cap
- $85.87B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Regeneron Pharmaceuticals, Inc. REGN:BOATS stock context
This page tracks Regeneron Pharmaceuticals, Inc.'s REGN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REGN:BOATS. REGN:BOATS is the stock-level entry point for investors researching Regeneron Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regeneron Pharmaceuticals, Inc. is a public company traded on the American stock market under the ticker REGN. The company has a market capitalization of approximately $68.8 billion. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.
Latest news from Regeneron Pharmaceuticals, Inc.
Veeva Vault CRM Selected by Regeneron
August 25, 2026
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and...
August 19, 2026
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
July 31, 2026
Regeneron Reports Second Quarter 2026 Financial and Operating Results
July 30, 2026
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
June 25, 2026
Research Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for REGN:BOATS.
Regeneron Pharmaceuticals, Inc. company profile
View the public company page for Regeneron Pharmaceuticals, Inc. on 6ix.
Regeneron Pharmaceuticals, Inc. news
Read company news and market updates connected to Regeneron Pharmaceuticals, Inc..
Regeneron Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Regeneron Pharmaceuticals, Inc..
Alternate listings
REGN:NASDAQ
US · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
RGO:GETTEX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
881535:LSX
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
RGO:TRADEGATE
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
REGN:BMV
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
REGN34:BMFBOVESPA
BR · BRL
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
RGO:FWB
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
0R2M:LSE
GB · USD
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
881535:LS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
RGO:DUS
DE · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
REGN:VIE
AT · EUR
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.
REGN:BIVA
MX · MXN
Alternate listing for Regeneron Pharmaceuticals, Inc.; the primary context on this page is REGN:BOATS.